Mitral Valve Replacement

Employing intravascular lithotripsy facilitated transcatheter mitral valve replacement in a patient with severe mitral annular and mitral valve leaflet calcification, according to a report on a first-in-human procedure.

BOSTON — A novel mitral valve transcatheter edge-to-edge repair system was noninferior to an existing system in a head-to-head trial in patients with severe symptomatic degenerative mitral regurgitation, researchers reported at TCT 2022.

Edwards Lifesciences announced the FDA approved the Mitris Resilia surgical valve, a tissue valve replacement specifically designed for the heart's mitral position.

Healio and Cardiology Today have curated a list of the most-read headlines from TCT 2021.

At 30 days, a group of 15 patients who underwent transfemoral transcatheter mitral valve replacement for moderate to severe mitral regurgitation had no deaths, strokes, reinterventions or new pacemakers, a speaker reported.

Abbott announced the FDA has approved its next-generation stented bioprosthetic surgical valves for the treatment of aortic or mitral valve disease.

Chewing gum may aid in accelerating gut function among patients who received cardiac surgery, according to new data presented at the virtual Society of Thoracic Surgeons Perioperative and Critical Care Conference.

Abbott announced its transcatheter mitral valve replacement system has received a breakthrough device designation from the FDA.

Mitral valve replacement using a novel transfemoral implantation system was successful in patients with severe mitral regurgitation at high surgical risk, according to findings presented at the virtual TCT Connect.

Among patients who underwent transcatheter mitral valve replacement for severe mitral regurgitation, 93% of those who survived to the 2-year follow-up had trace or no mitral regurgitation, researchers reported.